What is the next management step for a 64-year-old woman with coronary artery disease, scleroderma, uncontrolled type 2 diabetes mellitus presenting with chest pain, intermittent hoarseness, sore throat, fatigue, stable vital signs, clear respiratory exam, and a prolonged QT interval on ECG?

Immediate Management of Prolonged QT Interval with Acute Coronary Syndrome Evaluation

This patient requires immediate hospitalization with continuous cardiac monitoring, urgent evaluation for acute coronary syndrome (ACS), and comprehensive assessment of QT-prolonging factors including electrolyte abnormalities and medications. 1

Initial Emergency Assessment (<10 Minutes)

Obtain 12-lead ECG immediately to assess for ST-segment elevation myocardial infarction (STEMI) or other acute ischemic changes, as chest pain with known coronary artery disease represents possible ACS until proven otherwise. 1

• Measure cardiac troponin as soon as possible after presentation, as this patient has chest pain with known CAD and multiple risk factors (diabetes, age >60). 1
• Check vital signs and oxygen saturation; if O2 sat <94%, start oxygen at 4 L/min. 1
• Establish IV access and obtain initial electrolyte panel (potassium, magnesium, calcium), complete blood count, renal function, and glucose level. 1

Critical QT Interval Management

Immediately identify and correct reversible causes of QT prolongation, as QTc >500 ms or ΔQT >60 ms from baseline significantly increases risk of torsades de pointes. 1

• Review all medications for QT-prolonging drugs (www.crediblemeds.org) and discontinue any non-essential agents. 1
• Correct electrolyte abnormalities aggressively: hypokalemia, hypomagnesemia, and hypocalcemia are critical precipitants of torsades de pointes and must be normalized. 1
• Assess thyroid function at least once, as thyroid disease can prolong QT interval and is relevant given the patient's multiple comorbidities. 1
• Check renal function as acute kidney injury or chronic kidney disease can contribute to electrolyte abnormalities and QT prolongation. 1

Acute Coronary Syndrome Protocol

Administer aspirin 160-325 mg immediately (if not contraindicated) given the presentation of chest pain in a patient with established coronary artery disease. 1

• Consider sublingual nitroglycerin for chest discomfort, but monitor carefully given the prolonged QT interval. 1
• Administer morphine IV if discomfort is not relieved by nitroglycerin. 1
• Obtain portable chest x-ray within 30 minutes to exclude alternative diagnoses and assess for pulmonary edema. 1

Risk Stratification and Monitoring

Admit to a monitored telemetry unit or coronary care unit with continuous ECG monitoring, as this patient has definite high-risk features: known CAD, chest pain, prolonged QT interval, diabetes, and multiple cardiovascular risk factors. 1

• Repeat ECG and cardiac biomarkers at predetermined intervals (typically 3-6 hours) if initial troponin is negative. 1
• Monitor ECG continuously for QT interval changes and development of ventricular arrhythmias, particularly torsades de pointes. 1
• Increase frequency of ECG monitoring if QTc remains >500 ms despite correction of reversible factors. 1

Diabetes Management Considerations

Optimize glycemic control urgently, as hyperglycemia is an independent risk factor for high-risk QTc prolongation (≥500 ms) in patients with type 2 diabetes and coronary heart disease. 2

• Mean blood glucose level is a strong predictor of both QTc prolongation and high-risk QTc in diabetic patients with coronary disease. 2
• Uncontrolled diabetes increases the likelihood of CAD and negatively impacts prognosis in ACS. 1, 3

Scleroderma-Specific Considerations

Recognize that primary cardiac involvement from scleroderma can cause chest pain, palpitations, conduction abnormalities, and myocardial fibrosis independent of coronary disease. 4

• Scleroderma patients may have intramural coronary artery lesions and contraction band necrosis contributing to symptoms. 4
• The combination of scleroderma and CAD increases complexity of chest pain evaluation. 4

Common Pitfalls to Avoid

• Do not delay transfer or hospitalization for outpatient testing when ACS is suspected with prolonged QT—this combination requires inpatient evaluation. 1
• Do not use AV nodal blocking agents (adenosine, calcium channel blockers, digoxin) if wide-complex irregular rhythm develops, as this could represent pre-excited atrial fibrillation. 1
• Do not assume chest pain is non-cardiac based on atypical features alone in a diabetic patient with known CAD, as atypical presentations are more common in diabetes. 1
• Do not overlook hoarseness and sore throat as potential indicators of medication side effects or alternative diagnoses, but prioritize cardiac evaluation first. 1

Definitive Next Steps After Stabilization

If troponin is elevated or ECG shows ischemic changes, proceed with early invasive strategy (coronary angiography) per ACS guidelines. 1

If initial workup is negative for ACS, perform stress testing (exercise or pharmacological) within 72 hours while maintaining inpatient monitoring given the prolonged QT interval. 1